We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
Cap. Flow
+$208M
Cap. Flow %
11.48%
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$9.12M
2
V icon
Visa
V
+$8.75M
3
MSI icon
Motorola Solutions
MSI
+$7.37M
4
EW icon
Edwards Lifesciences
EW
+$7.3M
5
CTXS
Citrix Systems Inc
CTXS
+$4.48M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.1M
2
BHC icon
Bausch Health
BHC
+$5.94M
3
DE icon
Deere & Co
DE
+$5.72M
4
STZ icon
Constellation Brands
STZ
+$4.59M
5
QCOM icon
Qualcomm
QCOM
+$4.55M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 13.48%
3 Consumer Discretionary 12.62%
4 Technology 11.4%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYGN icon
26
Myriad Genetics
MYGN
$530M
$4.44M 0.25%
145,063
+15,735
+12% +$547K
NBIS
27
Nebius Group N.V.
NBIS
$47.7B
$4.41M 0.24%
201,729
-57,076
-22% -$1.11M
LEA icon
28
Lear
LEA
$7.19B
$4.4M 0.24%
43,211
+25,801
+148% +$2.9M
AMED
29
DELISTED
Amedisys
AMED
$4.38M 0.24%
86,677
+48,800
+129% +$2.46M
DIS icon
30
Walt Disney
DIS
$165B
$4.3M 0.24%
43,953
+23,274
+113% +$2.33M
SUPN icon
31
Supernus Pharmaceuticals
SUPN
$2.68B
$4.29M 0.24%
210,429
-41,680
-17% -$739K
DF
32
DELISTED
Dean Foods Company
DF
$4.23M 0.23%
234,021
+59,919
+34% +$1.06M
CPLA
33
DELISTED
Capella Education Company
CPLA
$4.22M 0.23%
80,093
+18,913
+31% +$986K
PDLI
34
DELISTED
PDL BioPharma, Inc.
PDLI
$4.15M 0.23%
1,322,151
+417,127
+46% +$1.39M
HUM icon
35
Humana
HUM
$46.7B
$4.14M 0.23%
23,009
+11,666
+103% +$2.07M
WM icon
36
Waste Management
WM
$95.9B
$4.01M 0.22%
60,524
+29,419
+95% +$1.78M
SPG icon
37
Simon Property Group
SPG
$74.5B
$3.92M 0.22%
18,050
+6,570
+57% +$1.34M
FPRX
38
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.9M 0.22%
94,425
+3,563
+4% +$155K
ANIP icon
39
ANI Pharmaceuticals
ANIP
$1.77B
$3.89M 0.22%
69,710
+3,364
+5% +$164K
FIZZ icon
40
National Beverage
FIZZ
$2.87B
$3.88M 0.21%
123,392
+3,000
+2% +$76.5K
BWXT icon
41
BWX Technologies
BWXT
$16B
$3.84M 0.21%
107,356
+34,482
+47% +$1.18M
MED icon
42
Medifast
MED
$108M
$3.83M 0.21%
114,988
+9,042
+9% +$292K
TAP icon
43
Molson Coors Class B
TAP
$7.68B
$3.8M 0.21%
37,584
+22,465
+149% +$2.21M
UNH icon
44
UnitedHealth
UNH
$382B
$3.79M 0.21%
26,855
+18,998
+242% +$2.53M
PLD icon
45
Prologis
PLD
$138B
$3.72M 0.21%
+75,935
New +$3.57M
ALK icon
46
Alaska Air
ALK
$5.15B
$3.72M 0.21%
+63,851
New +$4.41M
VG
47
DELISTED
Vonage Holdings Corporation
VG
$3.68M 0.2%
602,650
+28,111
+5% +$133K
BRSS
48
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$3.67M 0.2%
134,307
+3,751
+3% +$99.6K
MAC icon
49
Macerich
MAC
$7.32B
$3.65M 0.2%
42,762
-16,025
-27% -$1.25M
PXD
50
DELISTED
Pioneer Natural Resource Co.
PXD
$3.65M 0.2%
24,125
-7,129
-23% -$1.12M
1
2
3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

GSA Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.

  • GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
  • GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
  • GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
  • GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
  • GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
  • GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
  • GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.